Advertisement

Topics

Non-medicated VALCHLOR Demonstration Gel | Non-medicated VALCHLOR Demonstration [Actelion Pharmaceuticals US, Inc.] | BioPortfolio

13:32 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Non-medicated VALCHLOR Demonstration Gel DOES NOT contain mechlorethamine (the medicine in VALCHLOR).

The purpose of VALCHLOR Demonstration Gel is to show healthcare providers and patients how to properly apply VALCHLOR. This will also allow the user to experience the consistency of VALCHLOR and how it may feel on the skin.

This information does not take the place of talking to your healthcare provider about your condition or your treatment.

How should VALCHLOR Demonstration Gel be used?

How to use VALCHLOR Demonstration Gel:

Some Important Do's and Don'ts about VALCHLOR Demonstration Gel:

This demonstration gel contains the following nonactive ingredients: diethylene glycol monoethyl ether, propylene glycol, isopropyl alcohol, glycerin, lactic acid, hydroxypropylcellulose, sodium chloride, menthol, edetate disodium, and butylated hydroxytoluene.

Please see VALCHLOR full Prescribing Information including Medication Guide for information for active drug product.

To report SUSPECTED ADVERSE REACTIONS to the VALCHLOR Demonstration Gel, contact Actelion Pharmaceuticals US, Inc., at 1-855-4-VALCHLOR (1-855-482-5245) or FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.

The NDC code for the Non-medicated VALCHLOR Demonstration Gel is 66215-001-05.

ACT20151217

STEP 1: Open the 5g tube, use cap to puncture seal
STEP 2: Squeeze a small pea-sized amount on your fingertip
STEP 3: Gently spread a thin layer of the gel to dry healthy skin
STEP 4: Allow the gel to dry before covering with clothing (5 to 10 minutes after applying)
STEP 5: Throw the tube away in the household trash
STEP 6: Wash your hands with soap and water

Non-medicated VALCHLOR Demonstration Gel 5 grams

For demonstration purposes only. Does not contain active ingredient.For topical use only.

NDC 66215-001-05

Manufacturer

Actelion Pharmaceuticals US, Inc.

Active Ingredients

Source

Drugs and Medications [22 Associated Drugs and Medications listed on BioPortfolio]

Valchlor [helsinn therapeutics (u.s.), inc.]

These highlights do not include all the information needed to use VALCHLOR safely and effectively. See full prescribing information for VALCHLOR. VALCHLOR (mechlorethamine) gel, for topical use Initia...

Sodium sulfacetamide [e. fougera & co., a division of nycomed us inc.]

SODIUM SULFACETAMIDE Medicated Pads 10%

Valchlor [actelion pharmaceuticals us, inc.]

These highlights do not include all the information needed to use VALCHLOR safely and effectively. See full prescribing information for VALCHLOR. VALCHLOR (mechlorethamine) gel, for topical use Initia...

Silver nitrate applicator [bray group limited]

NA

Avoca flexible caustic applicator [bray group limited]

NA

Clinical Trials [236 Associated Clinical Trials listed on BioPortfolio]

Valchlor in the Treatment of Lichen Planopilaris

The primary objective of this study is to assess the potential effectiveness of once daily application of Valchlor in decreasing disease activity in patients with Lichen Planopilaris. The ...

Mechlorethamine Induced Contact Dermatitis Avoidance Study

This is a two-arm, open-label study that aims to compare the incidence and severity of the most common adverse reactions, particularly contact dermatitis, when Valchlor is used alone or in...

Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides

The clinical efficacy of mechlorethamine gel (Valchlor) as a maintenance therapy after low dose total skin electron beam therapy (TSEBT) for the treatment mycosis fungoides cutaneous T-cel...

A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia

This study was performed to evaluate the local and systemic safety profile and the analgesic efficacy of long-term treatment with lidocaine 5% medicated plaster (Lido-Patch). The study wa...

pK of a Novel 200 mg Ibuprofen Medicated Plaster

This is a Phase I study of the pharmacokinetics of a novel 200 mg Ibuprofen Medicated Plaster. The study will be conducted as a monocentric, open, randomised, single and multiple-dose, two...

PubMed Articles [408 Associated PubMed Articles listed on BioPortfolio]

Evaluation of the leaching of florfenicol from coated medicated fish feed into water.

Florfenicol is one of the most-used antimicrobial agents in global fish farming. Nevertheless, in most countries, its use is not conducted in accordance with good practices. The aim of this work was t...

Effect of medicated thread moxibustion on apoptosis of hippocampal neurons in rat models of chronic cerebral ischemic vascular dementia.

To investigate the effect of medicated thread moxibustion onapoptosis in hippocampal neuronsin a rat model of chronic cerebral ischemic vascular dementia. A total of 40 male Wistar rats were randomly ...

Attention deficit hyperactivity disorder late birthdate effect common in both high and low prescribing international jurisdictions: systematic review.

Multiple studies have found that the youngest children in a classroom are at elevated risk of being diagnosed with, or medicated for, ADHD. This systematic review was conducted to investigate whether ...

Influence of Topical Formulations: Lipid Lamella Organization and Lipid Composition of Stratum Corneum as a Surrogate Marker for Barrier Integrity.

Skin barrier repair therapies often involve the use of medicated and non-medicated topical preparations. To measure the effect of topical preparations, clinical (scoring systems, for example, Score of...

Cross-site Monitoring and Evaluation of the Care and Prevention in the United States Demonstration Project, 2012-2016: Selected Process and Short-term Outcomes.

The Care and Prevention in the United States (CAPUS) Demonstration Project was a 4-year (2012-2016) cross-agency demonstration project that aimed to reduce HIV/AIDS-related morbidity and mortality amo...

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record